Takeda Pharmaceutical Company Limited (TYO:4502)
5,155.00
-21.00 (-0.41%)
Jun 30, 2026, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or -0.90% compared to the previous year.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
95.81M JPY
Profits / Employee
-3.24M JPY
Market Cap
8.18T
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eisai | 10,543 |
| Toho Holdings | 7,609 |
| Shionogi & | 6,223 |
| Towa Pharmaceutical | 4,788 |
| Tsumura & Co. | 4,272 |
| Sumitomo Pharma | 3,832 |
| Sawai Group Holdings | 3,310 |
| Nippon Shinyaku | 2,243 |
Takeda Pharmaceutical Company News
- 5 days ago - Takeda Appoints Julie Kim President & CEO Following 18-Month Transition As Weber Retires - Nasdaq
- 5 days ago - Takeda CEO Christophe Weber retires, Julie Kim succeeds - TheFly
- 5 days ago - Takeda Names Julie Kim CEO As Christophe Weber Retires - Nasdaq
- 6 days ago - Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEO - Business Wire
- 6 days ago - Takeda Canada reports ‘positive’ results from Phase 3 study of zasocitinib - TheFly
- 6 days ago - Takeda Canada Announces Positive Topline Results For Phase 3 LATITUDE Atlas Study For Psoriasis - Nasdaq
- 14 days ago - Takeda Releases New Positive Phase 3 FirstLight And RadiantLight Data For Oveporexton In Narcolepsy - Nasdaq
- 14 days ago - Takeda presents additional results from oveporexton studies at SLEEP 2026 - TheFly